NCT00590668View on ClinicalTrials.gov

Safety Monitoring of Patients Having Pulmonary Vein Ablation

CompletedOBSERVATIONAL
Enrollment

42

Participants

Timeline

Start Date

May 31, 2004

Primary Completion Date

April 30, 2008

Study Completion Date

April 30, 2013

Conditions
Atrial Fibrillation
Interventions
DIAGNOSTIC_TEST

Transesophageal Echocardiography

Measurement of peak diastolic flow velocity

Trial Locations (1)

44195

Cleveland Clinic, Cleveland

All Listed Sponsors
lead

The Cleveland Clinic

OTHER

NCT00590668 - Safety Monitoring of Patients Having Pulmonary Vein Ablation | Biotech Hunter | Biotech Hunter